
MiMedx Group (MDXG) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
MiMedx Group (MDXG) last issued guidance on July 29, 2026 for fiscal year 2026. The company guided revenue in the range of $260M - $290M for the period.
Compared to prior guidance, MiMedx Group maintained its revenue forecast from a prior range of $260M - $290M.
MiMedx Group has issued 7 guidance updates between November 2, 2022 and July 29, 2026. During this period, the company raised its outlook 1 time and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.03 | $-0.04 | $0.10 | $0.07 |
| Actual | $-0.05 | $-0.05 | $0.14 | $0.15 |
| Surprise | -66.7% | -25.0% | +40.0% | +114.3% |
| Revenue | ||||
| Estimate | $63.5M | $64.0M | $105.2M | $94.8M |
| Actual | $64.4M | $59.0M | $118.1M | $113.7M |
| Surprise | +1.42% | -7.88% | +12.3% | +20.0% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $0.01 | $0.03 |
| Revenue | ||
| Consensus | $69.8M | $76.8M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $-0.05 | $-0.03 | -66.7 % |
| Q1 | Apr 29, 2026 | $-0.05 | $-0.04 | -25.0 % |
| Q4 | Feb 25, 2026 | $0.14 | $0.10 | 40.0 % |
| Q3 | Oct 29, 2025 | $0.15 | $0.07 | 114.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $64.36M | $63.46M | 1.42 % |
| Q1 | Apr 29, 2026 | $58.99M | $64.04M | -7.88 % |
| Q4 | Feb 25, 2026 | $118.10M | $105.17M | 12.3 % |
| Q3 | Oct 29, 2025 | $113.73M | $94.75M | 20.0 % |